IP
IndiaPulse

INSECTICID

Small Cap

Insecticides (India) Limited

Industrials

Insecticides (India) Limited operates in Agrochemicals, within the Industrials sector. Use the latest filing and company disclosures below to verify its revenue mix and current business drivers.

₹722.4
+17.80 · +2.53%
Quote09 Jun, 10:02 am
Fundamentals09 Jun 2026 · screener
Score08 Jun, 11:00 pm · v4.2-nightly
Tags02 May 2026
Data confidence
Fresh enough for analysis
Investor decision lenses

One read, four checks

75+ is strong, 60-74 is usable, 45-59 is mixed, and below 45 needs caution. These are research lenses, not buy/sell instructions.

Mixed fundamentals, management trust is supportive, price trend is neutral, and recent execution is mixed.

Suggested next step
Research, do not rush
The four lenses are not strongly aligned. Compare peers and wait for a cleaner setup.
U-Score
FAIR VALUE
51

Fundamental lens: valuation, quality, growth, balance sheet, and cash flow.

Trust
Healthy Trust
76

low confidence · 0/0 claims checked

Technical
Neutral
56

Timing lens: price trend and sector relative strength.

Result consistency
mixed
55

Rolling lens: recent quarterly delivery, not the latest single-result score.

Latest result

Quarter ended 31 Mar 2026

Bad · 2/100

PAT -14% YoY · margin compression · Rev +19% YoY · +11% QoQ

Filed 31 Mar 2026
Open results browser →
MetricThis quarterYoYQoQ
Revenue₹426 Cr+18.7%+10.7%
EBITDA₹25 Cr-10.7%-7.4%
Operating margin6.0%-200 bps-100 bps
PAT₹12 Cr-14.3%+20.0%
PAT margin2.8%-108 bps+22 bps

NDF means not disclosed in the current structured filing feed. It is intentionally not treated as zero.

Business and thesis

Issuer presentation review pending

Insecticides (India) Limited operates in Agrochemicals, within the Industrials sector. Use the latest filing and company disclosures below to verify its revenue mix and current business drivers. The structured result feed currently covers the quarter ended 31 Mar 2026. Investor presentations and earnings-call PDFs will be added as issuer-backed evidence before management claims appear here.

Technical timing lens

Trend score and candlestick chart

56Neutral

SMA20 +12.1% / mo

Stock trend: 59
Sector RS: 51
Sector 3M: +0.4% vs Nifty +0.1%

Technical chart

INSECTICIDdaily · 5Y+6.4%
Latest close ₹724.85 on 2026-06-09
Bar
+1.9%
RSI
52
MACD hist
-6.20
52W pos
80%
Hover for OHLC, volume, and indicators. Use range buttons above the chart to zoom.
₹506₹576₹647₹717₹78852H52L2025-122026-03Vol2025-112026-012026-022026-042026-06
Up bar
Down bar
Volume
Result date
SMA 50
RSI(14)

Technical trend read

Mixed signals

Signals are conflicting — long-term trend unclear. RSI 52. Wait for confirmation.

  • SMA20 rising (~3.5% over last month) — short-term momentum positive.
  • RSI(14) at 52 — sideways, no extreme reading.
  • MACD below signal, histogram expanding negatively — bearish momentum building.
  • 6% off 52W high · 40% above 52W low.

Mechanical read from the price + indicator series above. Not a recommendation — technical setups can reverse without warning, especially around earnings and macro events.

Deep research

Valuation, score drivers, trust methodology, financials, and peers

Use these sections after reviewing the decision summary, latest result, thesis, management accountability, and technical timing above.

51U-SCORE
Financial Turnaround

Fundamental score breakdown

FAIR VALUE
Valuation15/30
Growth10/25
Quality5/20
Balance Sheet12/15
Cash Flow4/10
Piotroski
8/9 (+5)
Penalties
0
Raw sum
51

Why this score?

Top U-Score contributors and drags from the latest stored fundamentals.

51/100 · FAIR VALUE

Positive drivers

  • Piotroski is strong at 8/9.
  • Fair-value margin of safety is positive at 21.1%.
  • Balance sheet contributes 12/15 to the score.

Main drags

  • Quality is weaker at 5/20; verify the latest quarterly trend.
  • Growth is weaker at 10/25; verify the latest quarterly trend.
  • Cash flow is weaker at 4/10; verify the latest quarterly trend.
Sector valuation model

Cyclical valuation: normalized earnings, not just trailing PE

Cyclical companies can look cheapest near peak profits, so IndiaPulse flags value-trap risk separately.

Cyclical normalized
Primary lens
Mid-cycle PE/EV/EBITDA using multi-year average margins or earnings.
Secondary checks
Current margin versus 5-year average, balance sheet strength, commodity cycle.
Main risk check
A low trailing PE may mean peak-cycle earnings, not true cheapness.
PE
15.1
PB
1.7
EV/EBITDA
8.6
ROE
12.1%
ROCE
15.9%
FCF Yield
0.7%
Debt/Equity
0.1
MoS
+21.1%
Cyclical/value-trap warning
This sector can look cheap when profits are temporarily high. Check mid-cycle margins/earnings before relying on trailing PE.
Score movement

Stored run vs live recompute

This shows the stored score trend when snapshots exist, and also compares the latest stored nightly score with a live recompute from current fundamentals and price.

Stored run: 08 Jun 2026
v4.2-nightly
Final score
51
Previous: 52 (-1)
Verdict
FAIR VALUE
Previous: FAIR VALUE
Margin of safety
+21.1%
Previous: +22.4%

Score history

12 stored score snapshots. Latest stored move: +1 points.

08 Jun 2026
v4.2-nightly
62
62
53
53
51
51
51
51
51
51
51
52

Factor attribution

Valuation
15-1
was 16
Trust Score
76Healthy Trust · low confidenceTrust Lite

Trust asks: does management behaviour match later outcomes? Higher is better, but confidence and evidence depth matter as much as the number.

Healthy Trust: Claim history is still being built. It ranks around the 82nd percentile of the scored universe and 80th percentile within Industrials. Main check: results consistency is weak at 55/100.

High Trust Lite: Promoter holding is 72.3%.

Computed 22 May 2026
trust-lite-v1
0 docs indexed · 0 concall links
Score band
Healthy Trust

Generally investable credibility. Look for weak sub-scores before increasing position size.

Relative rank
82nd percentile

overall median 67 · Industrials: 80th pctile, median 68 · Small: 85th pctile, median 65

Evidence depth
Financial-only

0 documents indexed, but claim history is not strong enough yet.

Claim delivery
Outcome history still building

0 claims extracted · No contradicted claim yet

How to read this Trust Score

Healthy Trust · low confidence
What it measures
Reliability of management and financial delivery, using financial behaviour only.
Confidence
Treat this as an early read until more concalls and outcomes are matched.
Investor use
Can support position sizing if valuation and trend also agree.

Read Trust alongside U-Score, result consistency, and technical trend. A cheap stock with weak Trust needs a larger margin of safety; a high Trust score does not make an expensive stock attractive by itself.

Forensic breakdown

Read low sub-scores as due-diligence warnings, not automatic sell signals.

Promoter
86
strong · holding, pledge, alignment
Cash flow
77
strong · profit to cash conversion
Balance sheet
89
strong · leverage and solvency
Discipline
68
acceptable · capital discipline
Results
55
watch · quarterly consistency

Trust positives

  • Promoter holding is 72.3%.
  • Promoter pledge is zero.
  • FCF yield is positive at 2.6%.
  • 8 years of positive FCF.

Trust risks

  • No major Trust Lite risk flags.

Trust Lite uses financial behaviour only. Prefer claim-tested Trust when enough concall claims have later outcomes.

Intrinsic value

Graham Number
₹672.07
-7.5% MoS
DCF Fair PE
19.1
DCF Fair Value
₹915.56
+21.1% MoS
PEG
1.35

Fundamentals

Valuation

P/E
15.10
P/B
1.73
EV/EBITDA
8.61
Market Cap
2107.00Cr

Profitability

ROE
12.10%
ROCE
15.90%
ROA
7.32%
Dividend Y
0.28%

Growth (CAGR)

Revenue 5Y
9.00%
EPS 5Y
7.00%
Revenue 3Y
6.00%
EPS 3Y
30.00%

Balance Sheet

Debt/Equity
0.13
Interest Coverage
13.35×
Altman Z
4.50
Book Value
419.00

Cash Flow

FCF Yield
0.66%
FCF Positive Y
8/5
OCF
100.00 Cr
EPS TTM
47.91

Shareholding

Promoter Hold
72.30%
Promoter Pledge
0.00%
Momentum 52W
36%

Financial History

Updated 9/6/2026

Revenue

₹ Cr
Latest: 2,140+18.8% vs prev
02140Mar 2015: 893Mar 2016: 906Mar 2017: 994Mar 2018: 1,073Mar 2019: 1,194Mar 2020: 1,363Mar 2021: 1,420Mar 2022: 1,504Mar 2023: 1,801Mar 2024: 2,140FY15FY16FY17FY18FY19FY20FY21FY22FY23FY24

Net Profit

₹ Cr
Latest: 102+61.9% vs prev
0123.0Mar 2015: 55.0Mar 2016: 40.0Mar 2017: 60.0Mar 2018: 84.0Mar 2019: 123Mar 2020: 87.0Mar 2021: 94.0Mar 2022: 107Mar 2023: 63.0Mar 2024: 102FY15FY16FY17FY18FY19FY20FY21FY22FY23FY24

Return on Equity

%
Latest: 10.1+46.9% vs prev
018.9Mar 2015: 18.9%Mar 2016: 9.8%Mar 2017: 12.9%Mar 2018: 15.3%Mar 2019: 18.6%Mar 2020: 11.9%Mar 2021: 11.4%Mar 2022: 12.3%Mar 2023: 6.9%Mar 2024: 10.1%FY15FY16FY17FY18FY19FY20FY21FY22FY23FY24
Verify on:NSE India ↗
All information is for study purposes only. For investment decisions, consult your financial advisor. See Playbook for methodology.